Hide metadata

dc.date.accessioned2020-03-05T19:26:01Z
dc.date.available2020-03-05T19:26:01Z
dc.date.created2019-06-21T12:53:23Z
dc.date.issued2019
dc.identifier.citationLindahl, Anne Karin . The 2018 establishment of a national expert panel for patients with serious life-threatening disease in Norway. Health Policy. 2019, 123(5), 468-471
dc.identifier.urihttp://hdl.handle.net/10852/73717
dc.description.abstractThe discussion on priority setting in Norwegian healthcare has resulted in several white papers and the establishment of a Council for priority setting from 2007−2017. In 2009 the Council discussed and proposed a system for renewed evaluation by an expert panel for cancer patients, as was in place in Denmark. However, the Directorate of Health found that patients already had the right of second opinion, and thus did not need a new expert panel like the one proposed. The case was discussed several times in the Council, coupled with the discussion on the inequity for patients to take part in studies of emerging treatments. This resulted in 2015 in a public website for patients with information on ongoing clinical trials open for inclusion, but no solution regarding the expert panel. A journalist in a national newspaper published a series of articles in the summer of 2017 on the topic. This was close to the election for Parliament, and the politicians got interested; first the opposition, then the current Minister of Health and Care services. The decision was made in August 2017 to establish such an expert panel for renewed evaluation for patients with serious lifeshortening disease Also, the information for patients on ongoing trials should be more complete and accessible. The Regional health authorities implemented the policy decision, and the expert panel was in place November 1st 2018.
dc.languageEN
dc.publisherElsevier Science
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleThe 2018 establishment of a national expert panel for patients with serious life-threatening disease in Norway
dc.typeJournal article
dc.creator.authorLindahl, Anne Karin
cristin.unitcode185,52,11,0
cristin.unitnameAvdeling for helseledelse og helseøkonomi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1706755
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Health Policy&rft.volume=123&rft.spage=468&rft.date=2019
dc.identifier.jtitleHealth Policy
dc.identifier.volume123
dc.identifier.issue5
dc.identifier.startpage468
dc.identifier.endpage471
dc.identifier.doihttps://doi.org/10.1016/j.healthpol.2019.01.006
dc.identifier.urnURN:NBN:no-76832
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0168-8510
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/73717/2/Lindahl_2019_The.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International